Chapman Investment Management, LLC Merck & Co., Inc. Transaction History

Chapman Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$113.24 - $131.95 $177,786 - $207,161	1,570 New	1,570 $207,000
Q1 2023 Apr 25, 2023	SELL	$102.94 - $114.86 $108,704 - $121,292	-1,056 Reduced 35.48%	1,920 $204,000
Q3 2022 Nov 01, 2022	SELL	$84.53 - $94.96 $12,679 - $14,243	-150 Reduced 4.8%	2,976 $256,000
Q1 2022 May 09, 2022	SELL	$73.51 - $82.4 $357,332 - $400,546	-4,861 Reduced 60.86%	3,126 $256,000
Q4 2021 Jan 20, 2022	SELL	$72.28 - $90.54 $225,802 - $282,846	-3,124 Reduced 28.12%	7,987 $612,000
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $50,176 - $55,181	700 Added 6.72%	11,111 $835,000
Q2 2021 Aug 03, 2021	BUY	$70.31 - $77.77 $77,130 - $85,313	1,097 Added 11.78%	10,411 $810,000
Q4 2020 Jan 26, 2021	BUY	$71.77 - $79.65 $72,774 - $80,765	1,014 Added 12.22%	9,314 $762,000
Q3 2020 Oct 14, 2020	BUY	$73.18 - $82.95 $607,394 - $688,485	8,300 New	8,300 $688,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Chapman Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chapman Investment Management, LLC with notifications on news.